Counterpoint: Impaired fasting glucose: The case against the new American diabetes association guidelines

Diabetes Care

Volumn 29, Issue 5, 2006, Pages 1173-1175

  Dekker, Jacqueline M ^a,c   Balkau, Beverley ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSERM   (France)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CRITERION VARIABLE; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; MEDICAL SOCIETY; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PUBLIC HEALTH; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 33746329620     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc05-2220     Document Type: Editorial

References (23)

1. MacFarlane IA, Bliss M, Jackson JGL, Williams G: The history of diabetes melllitus. In Textbook of Diabetes. 2nd ed. Pickup J, Willams G, Eds. London, Blackwell Science, 1997
2. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no 727)
3. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
4. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999 (WHO/NCD/NCS/99.2)
5. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ: Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn study. JAMA 285:2109-2113, 2001
6. de Vegt F, Dekker JM, Ruhé HG, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ: Hyperglycaemia is associated with allcause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926-931, 1999
7. The DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-405, 2001
8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
9. Davidson MB, Landsman PB, Alexander CM: Lowering the criterion for impaired fasting glucose will not provide clinical benefit (Editorial). Diabetes Care 26:3329-3330, 2003
10. Borch-Johnson K, Colaiuri S, Balkau B, Glümer C, Carstensen B, Ramachandran A, Dong Y, Gao W: Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycemia. Diabetologia 47:1396-1402, 2004
11. Tai ES, Goh SY, Lee JJM, Wong MS, Heng D, Hughes K, Chew SK, Cutter J, Chew W, Gu K, Chia KS, Tan CE: Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27:1728-1734, 2004
12. Balkau B, Hillier T, Vierron E, D'Hour A, Lépinay P, Royer B, Born C: Comment to: Borch-Johnsen K, Colagiuri S, Balkau B, et al. (2004): Creating a pandemic of pre-diabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 48:801-802, 2005
13. Vaccaro O, Riccardi G: Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care 28:1786-1788, 2005
14. Ford E: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: summary of the evidence. Diabetes Care 28:1769-1798, 2005
15. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE, the ARIC Investigators: Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28:2013-2018, 2005
16. Vegt F de, Dekker JM, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ: Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care 23:40-44, 2000
17. Balkau B, Bertrais S, Ducimetiere P, Eschwege E: Is there a glycemic threshold for mortality risk? Diabetes Care 22:696-699, 1999
18. The DECODE Study Group, the European Diabetes Epidemiology Group: Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and no cardiovascular diseases? Diabetes Care 26:688-696, 2003
19. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Bittner V, Cauley JA, Hulley S, Barrett-Connor E: Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann Intern Med 142:813-820, 2005
20. Wen CP, Cheng TYD, Tsai SP, Hsu HL, Wang SL: Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 28:2756-2761, 2005
21. Sorkin JD, Muller DC, Fleg JL, Andres R: The relation of the fasting and 2-h post-challenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28:2626-2632, 2005
22. Ferrannini E, Gastaldelli A, Miyazaki Y, Masuda M, Mari A, DeFronzo RA: B-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493-500, 2005
23. American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 28(Suppl. 1):S37-S42, 2005